Evidence map›Paper›PMID 26571425›Full record

ArticleJournal of immunological methods2015

Methodology for preservation of yeast-bound single chain fragment variable antibody affinity reagents.

Maria Kahn, Scott Priddy, Marcus Estrada, Lauren Spadafora, Gerard A Cangelosi, Gonzalo J Domingo

Abstract read
In one paragraph

Article in Journal of immunological methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria KahnPATH, Seattle, WA, United States.
Scott PriddyEurofins Lancaster Labs, Thousand Oaks, CA, United States.
Marcus EstradaPATH, Seattle, WA, United States.
Lauren SpadaforaUniversity of Washington, Seattle, WA, United States.
Gerard A CangelosiUniversity of Washington, Seattle, WA, United States.
Gonzalo J DomingoPATH, Seattle, WA, United States. Electronic address: gdomingo@path.org.

Funding

Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Accelerated molecular probe pipelineU01AI082186 · NIAID · UNIVERSITY OF WASHINGTON · PI CANGELOSI, GERARD A · 2009 to 2013
$4.7M
NIAID NIH HHS T32 AI007509NIAID NIH HHS U01 AI082186NIAID NIH HHS U01AI082186
6 · The paper itself

Abstract

Readily accessible affinity reagents are critical to the validation of biomarkers and to the development of new diagnostic tests. As alternatives to monoclonal antibodies, yeast-bound single chain fragment variable antibody (yeast-scFv) can be rapidly selected from yeast display libraries. An important characteristic for any diagnostic reagent is its stability or ability to store it. A lyophilization procedure that has extended the shelf life of yeast-scFv by a factor of ≥10-fold relative to previous reports is reported. Real time stability for three yeast-scFv clones to three distinct Entamoeba histolytica potential diagnostic antigen targets for one year at room temperature as well as at 37°C and 45°C. Retention of full binding activity and specificity of the yeast-scFv clones for their cognate antigens is shown by flow cytometry. Lyophilization can easily be carried out in batches and in single-use vials.

Indexed as

Drug StabilityReagent Kits, DiagnosticSingle-Chain AntibodiesDrug StorageFlow CytometryFreeze DryingYeastsReagent Kits, DiagnosticSingle-Chain AntibodiesDiagnosticsNeglected tropical diseasesYeast display

Identifiers

PMID26571425
PMCPMC4679506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.